Non-constant hazard ratios in randomized controlled trials with composite endpoints

Jordi Cortés Martínez, Moisès Gómez Mateu, KyungMann Kim +1

The hazard ratio is routinely used as a summary measure to assess the treatment effect in clinical trials with time-to-event endpoints. It is frequently assumed as constant over ti…